Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:acquiredBy |
gptkb:VWR_International
|
| gptkbp:category |
gptkb:chemical_compound
Fortune 500 company life sciences company |
| gptkbp:CEO |
gptkb:Michael_Stubblefield
|
| gptkbp:founded |
1904
|
| gptkbp:founder |
gptkb:John_Townsend_Baker
|
| gptkbp:headquartersLocation |
gptkb:Radnor,_Pennsylvania,_United_States
|
| gptkbp:industry |
life sciences
chemicals |
| gptkbp:ISIN |
US05352A1007
|
| gptkbp:numberOfEmployees |
~14,500
|
| gptkbp:parentCompany |
New Mountain Capital (prior to IPO)
|
| gptkbp:products |
gptkb:industrial_equipment
consumables laboratory chemicals biopharmaceutical ingredients |
| gptkbp:revenue |
~$7.5 billion (2023)
|
| gptkbp:servesArea |
worldwide
|
| gptkbp:stockExchange |
gptkb:New_York_Stock_Exchange
|
| gptkbp:stockSymbol |
gptkb:AVTR
|
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
https://www.avantorsciences.com/
|
| gptkbp:bfsParent |
gptkb:New_Mountain_Capital
gptkb:Thermo_Fisher_Scientific gptkb:VWR_International |
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Avantor
|